_edited.png)
Avisa Asemi
Ph.D., HCLD
Practicing Since
1999
Languages (Staff)
Board Certificationsļ¼
American Board of Obstetrics & Gynecology (ABOG) ā Certified in Reproductive Endocrinology & Infertility
American Board of Obstetrics & Gynecology (ABOG) ā Certified in Obstetrics & Gynecology
Categories:
Fertility Lab Specialties, Embryology, Andrology, Laboratories
Meet
Dr. Asemi
A Leader in Fertility Treatment
Dr. Avisa Asemi brings over two decades of expertise as a board-certified lab director, scientific director, team leader, and senior embryologist, having worked in renowned fertility centers across the U.S., Canada, and internationally. Her distinguished career includes positions at Stanford University's Fertility & Reproductive Health Center, the University of Miami Miller School of Medicine, Reproductive Medicine Associates of Northern California, Shady Grove Fertility Center, Northern California Fertility Center, Boca Fertility, and Markham Fertility Center, among others.
Dr. Asemi has successfully led several embryology and andrology labs in the U.S. and Canada, creating effective strategies for balancing high functionality with high productivity. Her extensive experience in diverse fertility centers has made her an expert in embryology and andrology labs, supported by her interdisciplinary knowledge and certifications, including a Doctor of Philosophy, HCLD, TS, and ELS Certifications from ABB.
As a specialist in reproductive medicine and laboratory science, Dr. Asemi has authored several research papers. Her journey into embryology began uniquely; after graduating with honors in microbiology, she applied to a local fertility center in Tehran, Iran, and was chosen from 150 candidates. This launched her career as an embryologist. She later pursued graduate degrees at Georgetown University and Florida Atlantic University, building on her education and experience in fertility.
Outside of work, Dr. Asemi likes to travel and has been to most European and Middle Eastern countries. Her favorite places to vacation are Italy and Spain. She also likes hiking, swimming and biking, exploring new trails, ideally next to water, so she can bike there weekly.
Part of These Trusted Organizations
American Society of Reproductive Medicine (ASRM)
ASRM Research Institute
IVF Innovation- AI scientific Advisory Board Member and Consultant
.
Why Intended Parent Trust
Dr. Asemi
Dr. Avisa Asemiās certifications, education from prestigious universities and more than 20 years of work experience in different types of fertility centers (private, academic and corporate) has equipped her with broad interdisciplinary knowledge in the field of reproductive medicine. Combining skills as a lab director, senior embryologist, andrologist developmental and gamete biologist, and a neuroendocrinologist.
Credentials
2021
2021
2015
2007
1998
Certified as Technical Supervisor (TS)
Certified as High Complexity Clinical Laboratory Director (HCLD)
Florida Atlantic University, Doctorate in Complex Systems and Brain SciencesĀ
Georgetown University, Master of Science, biochemistry and molecular biology
Al-Zahra University, Tehran, Iran. Bachelor of Science, Microbiology
Area of Work & Research
Dr. Asemiās work experience includes:
ā
- ICSI, nano surgery and trophectoderm biopsy (PGT-A, PGT-M, PGT-SR).
- Expertise in all embryology and andrology lab procedures.
- Competence with leading and directing diverse teams.
- FDA & CAP regulation and inspections.
- Startup IVF centers.
Dr. Avisa Asemiās special research interest is in oocyte (egg) maturity:
If embryologists can make the germinal vesicle, which is the enlarged nucleus of the egg before completion of meiosis (a type of cell division), to the meiosis II stage of division, that will make them functional.
Women are born with many immature eggs. Sometimes even after 50 years of age, there are still immature eggs in a womanās body.
Inducing the germinal vesicle to become mature and functional would give patients and the lab more eggs to use.
This would eventually increase the success rate, especially for patients with poor response to ovarian stimulation.
She believes this can happen in the next decade or so, and it is likely how the field used to view the then new ICSI procedure 20 years ago.
